What are the challenges associated with the Pneumococcal Conjugate Vaccine?
Despite its success, the PCV faces several challenges. One major issue is serotype replacement, where non-vaccine serotypes fill the ecological niche left by vaccine-covered serotypes, potentially leading to new waves of disease. Additionally, vaccine coverage and access remain a concern in low-resource settings, where the burden of pneumococcal disease is often highest.
